Hidradenitis Suppurativa Research Study (16 Weeks)

Men and women aged 18-75 years old with a diagnosis of hidradenitis suppurativa (HS) and disease lasting for at least 6 months, may qualify to participate in this study. Individuals must have moderate to severe hidradenitis suppurativa with lesions in at least 2 distinct areas.  A stable course of HS for at least 90 days before screening, will be determined by the study doctor.

Eligible participants will receive investigational oral medication (active drug or placebo).  Study medication and study-related care will be provided at no cost.  Reimbursement for study-related expenses may be provided. 

Study participation will last up to 16 weeks and include about 8 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Hidradenitis Suppurativa
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more